Reviewed by: Liz McKinney MS, CNS, LDN Liz has a Master of Science degree in Clinical Nutrition and Integrative Health and is a board-certified nutrition specialist (CNS) and a licensed dietitian nutritionist (LDN)
Patients who were overweight and suffered from diabetes mellitus participated in clinical trials, giving results that retinal disorders did occur in 6.9 % of patients who underwent Semaglutide treatment as compared to placebo patients with only 4.2 % occurrence of retinal impairment
Thirteen studies included only males or females (59, 63, 64, 69, 72, 73, 78, 80), and 28 included both sexes (6062, 6568, 70, 71, 74, 76, 77, 79)
Patients with very high LDL cholesterol or very low HDL cholesterol may benefit the most from semaglutide
Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses